Incidence and risk factors for development of new-onset diabetes after kidney transplantation

Yong-Mong BEE; Hong-Chang TAN; Tunn-Lin TAY; Terence-Ys KEE; Su-Yen GOH; Peng-Chin KEK.
Annals of the Academy of Medicine, Singapore ; : 160-167, 2011.
Artículo en Inglés | WPRIM | ID: wpr-237318

Documentos relacionados

  1. The impact of human leukocyte antigen mismatch on recipient outcomes in living-donor liver transplantation.
  2. HLA-B Matching Prolongs Allograft Survival in Islet Cell Transplantation.
  3. Incidence and risk factors for development of new-onset diabetes after kidney transplantation.
  4. Association of HLA B- and T-cell molecular mismatches with HLA antibodies, rejection, and graft survival in pediatric kidney transplantation.
  5. Platelet transfusions in haploidentical haematopoietic stem cell allograft candidates: Protecting HLA-A and HLA-B antigens through eplet analysis.
  6. Antibody verification of HLA class I and class II eplets by human monoclonal HLA antibodies.
  7. Development of an ARMS multiplex real-time PCR assay for the detection of HLA-B*13:01 genotype by detecting highly specific SNPs.
  8. Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study.
  9. Donor-specific antibodies, glomerulitis, and human leukocyte antigen B eplet mismatch are risk factors for peritubular capillary C4d deposition in renal allografts.
  10. HLA B eplet mismatches in the context of delayed graft function and low tacrolimus trough levels are risk factors influencing the generation of de novo donor-specific antibodies and acute rejection in the early stage after kidney transplantation.